Sonic Healthcare Limited
SHL
株式のランク
#2828
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
株価
$13.26
時価総額
$6.55B
変化（1日）
-0.21%
変化（1年）
-4.48%
国
AU
取引 Sonic Healthcare Limited (SHL)
カテゴリー
Healthcare
Sonic Healthcare Limited（SHL）の収益
Jun 2026 時点の収益 TTM: $7.72B
Sonic Healthcare Limited の最新の財務報告によると、現在の収益 (TTM) は $7.72B です。2024 年には $5.97B の収益があり、これは 2023 年の $5.43B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Sonic Healthcare Limited の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $7.72B | 21.62% |
| 2025 | $6.35B | 6.44% |
| 2024 | $5.97B | 9.92% |
| 2023 | $5.43B | -15.46% |
| 2022 | $6.42B | -2.19% |
| 2021 | $6.56B | 44.93% |
| 2020 | $4.53B | 5.12% |
| 2019 | $4.31B | 6.21% |
| 2018 | $4.06B | 4.22% |
| 2017 | $3.89B | 5.59% |
| 2016 | $3.69B | 15.59% |
| 2015 | $3.19B | -12.32% |
| 2014 | $3.64B | 16.17% |
| 2013 | $3.13B | -7.83% |
| 2012 | $3.40B | 2.73% |
| 2011 | $3.31B | 31.31% |
| 2010 | $2.52B | 4.80% |
| 2009 | $2.40B | 7.41% |
| 2008 | $2.24B | 42.62% |
| 2007 | $1.57B | 29.80% |
| 2006 | $1.21B | 16.78% |
| 2005 | $1.03B | 45.21% |
| 2004 | $712.48M | 10.16% |
| 2003 | $646.79M | 35.18% |
| 2002 | $478.47M | 51.42% |
| 2001 | $315.99M | 0.00% |
| 2000 | 0.00 | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 499.99% |
US
|
|
| $25.11B | 225.10% |
US
|
|
| $2.71B | -64.95% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -4.54% |
US
|
